Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Antibody-drug Conjugate
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : LegoChem Biosciences
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LegoChemBio Signs License Agreement to Acquire First-in-class Antibody From Elthera
Details : Under the terms of the licensing agreement, LegoChem Biosciences will develop and commercialize a novel antibody-drug conjugate (ADC) therapy using a monoclonal antibody developed by Elthera.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
February 13, 2023
Lead Product(s) : Antibody-drug Conjugate
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : LegoChem Biosciences
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?